Price movement over the last 24 hours
Alkindo Naratama Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Alkindo Naratama Tbk trades at Rp690 (market cap 1.89T, 1.7K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 1.74M 24h volume). The key difference: Alkindo Naratama Tbk is far larger — about 5.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (1.74M versus 1.7K). Which is the better fit depends on your goals.
| ALDO | DGNS | |
|---|---|---|
Market Cap | 1.89T | 319B |
Volume | 1.7K | 1.74M |
Lot | 17 | 17.44K |
Turnover | 1.17M | 400.92M |
Average Price | 688.24 | 229.87 |
Value | 1.17M | 400.92M |
Indicative Equilibrium Price | 690 | 232 |
Indicative Equilibrium Volume | 1 | 212 |
Trailing returns across standard periods
Latest headlines on both assets
PT Alkindo Naratama Tbk (the "Company") was established based on Notarial Deed No 74 of Kikit Warianti SH, dated January 31, 1989. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 5 of Nunuy Rahmayati SH dated March 15, 2011 pertaining of Authorized share and paid-up capital, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity
Read more on ALDO →PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →